Loading…
Tuesday, June 26 • 2:00pm - 3:15pm
#259: Measuring the Impact of Patient Engagement: What to Ask Depends on Who You Ask

Sign up or log in to save this to your schedule and see who's attending!

Tweet Share
Component Type: Session
Level: Intermediate
CE: ACPE 1.25 Knowledge UAN: 0286-0000-18-704-L04-P; CME 1.25; IACET 1.25; RN 1.25

Meaningful engagement with patients is planned with a purpose, and as it is more fully integrated into the medical product life cycle, measuring its impact is increasingly important. Patients, sponsors, and regulators want to know if their expected outcomes have been achieved. How to measure the impact of patient engagement depends on your viewpoint. In this session, stakeholders discuss their perspectives on the outcomes they might expect from patient engagement and what types of measures can signal achievement. A case example of evaluating the impact of a patient engagement effort from the dual perspectives of patient satisfaction and clinical development deliverables will be examined.

Learning Objectives

Describe the relationship of expected outcomes of patient engagement to impact measurements; Identify one outcome of patient engagement that is important to each key stakeholder; Discuss possible measures to assess the impact of patient engagement from the perspective of each key stakeholder.

Chair

Roslyn F Schneider

Speaker

Thank You! The Power of Gratitude to Improve Clinical Development Quality
Mary Stober Murray, MBA

Patient Engagement
Ellen Coleman, MPH, MS

Patient Perspective
Suzanne Schrandt, JD


Speakers
avatar for Ellen Coleman

Ellen Coleman

President & CEO, MK&A
Ellen Coleman is Senior Vice President at MK&A, a global industry consulting firm specializing in patient and healthcare stakeholder engagement strategies (www.mkanda.com). She brings considerable experience with patients who have chronic and life-threatening illnesses such as cancer... Read More →
avatar for Ellen Coleman

Ellen Coleman

President & CEO, MK&A
Ellen Coleman is President & CEO at MK&A, a global industry consulting firm specializing in patient and healthcare stakeholder engagement strategies (www.mkanda.com). She brings considerable experience with patients who have chronic and life-threatening illnesses such as cancer and... Read More →
avatar for Mary Murray

Mary Murray

Associate Director, Diversity and Patient Engagement, Bristol-Myers Squibb
As an Associate Director for Diversity and Patient Engagement at Bristol-Myers Squibb, Mary facilitates collaborations with disease-specific and community-based organizations to bring relevant clinical trial options to patients and representative populations. Mary has co-chaired the... Read More →
avatar for Roslyn Schneider

Roslyn Schneider

Global Patient Affairs Lead, Pfizer Inc
Roz leads Global Patient Affairs at Pfizer, a hub of patient centricity, driving integration of patient experiences and perspectives across the company and the product lifecycle. She held roles in Medical Affairs, Medical Strategy and Medicine Development for twelve years at Pfizer... Read More →
avatar for Suzanne Schrandt

Suzanne Schrandt

Director, Patient Engagement, Arthritis Foundation
Suz Schrandt, JD, is Patient Engagement Director at the Arthritis Foundation. She was previously Deputy Director, Patient Engagement for PCORI, where she helped to launch key efforts including the Engagement Rubric. Schrandt's patient engagement focus stems from her own rheumatological... Read More →

Tuesday June 26, 2018 2:00pm - 3:15pm
Room 254AB Boston Convention and Exhibition Center 415 Summer Street, Boston, MA 02210 USA
  05: Patient Engagement, Session